THE EXPERIENCE OF THEALOZ EYE DROPS INSTILLATION FOR PATIENTS AFTER LASER IN-SITU KERATOMILEUSIS

Abstract

Laser refraction surgery is currently one of the most wide-spread surgeries in ophthalmology. It is known that during the process of refraction stabilization and even afterwards the patients are often disturbed by the feeling of eye dryness, discomfort during minimal visual efforts. The purpose of this study is observation of the results tear substitute therapy with medical device Thealoz for patients after LASIK and evaluation of its effectiveness as a preventive mean in the development of dry eye desease (DED). Material and methods. 30 people aged 18-51 years (average age 28 years) undergoing laser in-situ keratomileusis surgery (LASIK) were observed. After a week after the surgery instillation of antibiotic drops, orticosteroids and eye lubricants of medium viscosity stopped. Further treatment included only one medicine - Thealoz, 4 times a day within 30 days. Results. In all cases, the planned visual acuity was achieved, in some cases determined by the initial complexity of refraction anomaly. An increase of the Shirmer test score was registered from the first visit (one week after surgery) by the end of the first month - 9.58 ± 2.71 and 15.47 ± 2.44 respectively. The positive dynamics in BUT-test scores was recorded between the two specified dates: 14.53 ± 3.78 and 21.83 ± 3.55 respectively. Conclusion. The instillation of eye drops Thealoz is effective in preventing the development of DED after LASIK. For citation: Bogush I.V., Burilov K.B., Bratko G.V., Chernykh V.V. The experience of Thealoz eye drops instillation for patients after laser in-situ keratomileusis. Russian ophthalmological journal. 2018; 11 (2): 41-4. doi: 10.21516/2072-0076-2018-11-2-41-44 (In Russian).

Keywords

• синдром сухого глаза
• ласик
• слезозаместительной терапия
• dry eye desease
• lasik
• tear substitute therapy